NCT00229580

Brief Summary

The purpose of this study was to explore whether a brief (3 session) intervention would impact health behavior of veterans with hepatitis C. The main focus of the intervention was on reduction of heavy drinking with patients who have liver disease. Other study goals were to increase the likelihood that patients would seek out substance use treatment and/or hepatitis C health care services. The study also tested the use of a liver function test called CDT/GGT in detecting heavy drinking. The main hypothesis was that a 3 session intervention with personalized feedback about health behavior would result in a reduction in alcohol use and increased use of substance use treatment and hepatology health care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Dec 2003

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2003

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

September 27, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 29, 2005

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2006

Completed
Last Updated

November 30, 2007

Status Verified

November 1, 2007

First QC Date

September 27, 2005

Last Update Submit

November 28, 2007

Conditions

Keywords

Brief InterventionMotivational InterviewingHealth PsychologyAlcoholHepatitis CPatient Education

Outcome Measures

Primary Outcomes (1)

  • Reduction in alcohol consumption

    at 6 and 12-week follow-up.

Secondary Outcomes (1)

  • Engagement in substance use treatment and hepatitis C specialty care. Detection of elevated CDT in blood serum compared with self-reported heavy drinking.

    12 weeks post-study

Study Arms (2)

1

EXPERIMENTAL

Motivational feedback

Behavioral: 3 session brief intervention with health behavior feedback

2

ACTIVE COMPARATOR

treatment as usual

Other: treatment as usual

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Positive serology for current infection by hepatitis C viremia by PCR confirmation test;
  • Current alcohol use (past 30 days) as indicated by self-report (using AUDIT- C questions);
  • Meets hazardous alcohol use criteria as measured by the Alcohol Use Disorders Identification Test.
  • Criteria per (National Institute on Alcohol Abuse and Alcoholism, 1995):
  • for women, 7 or more drinks per week or 4 or more drinks per occasion;
  • for men, 14 or more drinks per week or 5 or more drinks per occasion;
  • Not currently engaged (past 30 days) in VA specialty substance use disorder treatment or mutual help groups like AA/NA.

You may not qualify if:

  • Abstinent from alcohol use in last 30 days as indicated by self-report or less than hazardous use according to criteria listed above by the AUDIT.
  • Patient is already engaged (past 30 days) in specialty substance use disorder treatment or attends self-help groups.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Puget Sound Health Care System

Seattle, Washington, 98108, United States

Location

MeSH Terms

Conditions

AlcoholismHepatitis CLiver Diseases

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersBlood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisDigestive System Diseases

Study Officials

  • Tania M Davis Correale, PhD

    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 27, 2005

First Posted

September 29, 2005

Study Start

December 1, 2003

Study Completion

January 1, 2006

Last Updated

November 30, 2007

Record last verified: 2007-11

Locations